Gene · 25939
NIH grants2,175
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 2,175
Download this page as JSON| Grant | Title | SAMHD1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI162260 | A multiscale approach for elucidating nuclear entry mechanisms of HIV-1 capsid | 1 | 2025 |
| R01AI163216 | Developing three-dimensional antisense oligonucleotide drugs against COVID-19 | 1 | 2025 |
| R01AI167778 | Controlling HIV latency by manipulating CycT1 turnover | 1 | 2025 |
| R01AI170228 | Spatiotemporal Staging of the HIV-1 Preintegration complex | 1 | 2025 |
| R01AI177555 | A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities | 1 | 2025 |
| R01AI183286 | Targeting the transcriptionally-active reservoir to reduce chronic inflammation in aged people with HIV | 1 | 2025 |
| R01AI189220 | How SAMHD1 regulates HIV-1 innate immunity and viral gene expression | 1 | 2025 |
| R01AR046713 | Cytokine regulation of RA synoviocyte phenotype | 1 | 2025 |
| R01AR050401 | Cytokine Balance in Rheumatoid Arthritis | 1 | 2025 |
| R01AR071703 | Mechanisms of DNA-Specific Autoimmunity in Systemic Lupus Erythematosus | 1 | 2025 |
| R01CA132946 | Genomics of AML Prognosis | 1 | 2025 |
| R01CA136367 | Disruption of Cellular RNA Processing by Kaposi's Sarcoma-Associated Herpesvirus | 1 | 2025 |
| R01CA140337 | Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation | 1 | 2025 |
| R01CA152108 | Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML) | 1 | 2025 |
| R01CA154947 | Defining Pathogenic Mechanisms and Therapeutic Opportunities for Langerhans Cell Histiocytosis | 1 | 2025 |
| R01CA197774 | Regulation of DNA synthesis in response to DNA damage | 1 | 2025 |
| R01CA200900 | Systemic RNA Delivery to Tumors | 1 | 2025 |
| R01CA214799 | Compensatory Mechanisms that Promote Homologous Recombination in BRCA1 Mutant Cancers | 1 | 2025 |
| R01CA234266 | Molecular modulator of RAD51 in maintaining genome stability | 1 | 2025 |
| R01CA236853 | BCLW in lymphoma survival and resistance to targeted BCL2 family therapies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25939/grants?page=12